Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CAI Caris Life Sciences, Inc.

Post-Mkt 02-24 16:48:41 EST

18.20

+0.56

+3.17%

盘后18.20

+0.000.00%

16:10 EST

High18.44	Low17.15	Vol2.59M
Open17.53	D1 Closing17.64	Amplitude7.31%
Mkt Cap5.14B	Tradable Cap1.67B	Total Shares282.15M
T/O46.77M	T/O Rate2.81%	Tradable Shares91.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":18.2,"timestamp":1771966800000,"preClose":17.64,"halted":0,"volume":2586544,"hourTrading":{"tag":"盘后","latestPrice":18.2,"preClose":18.2,"latestTime":"16:10 EST","volume":14661,"amount":266830.2,"timestamp":1771967404167,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.031746031746031675,"floatShares":91917486,"shares":282146923,"eps":-2.417,"marketStatus":"Post-Mkt","change":0.56,"latestTime":"02-24 16:48:41 EST","open":17.53,"high":18.44,"low":17.15,"amount":46766161.881743,"amplitude":0.073129,"askPrice":19.09,"askSize":20,"bidPrice":18.2,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-2.417,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":17.64,"preHourTrading":{"tag":"盘前","latestPrice":17.6,"preClose":17.64,"latestTime":"09:27 EST","volume":1814,"amount":33166.6318,"timestamp":1771943260021,"change":-0.04,"changeRate":-0.002268,"amplitude":0.068027},"postHourTrading":{"tag":"盘后","latestPrice":18.2,"preClose":18.2,"latestTime":"16:10 EST","volume":14661,"amount":266830.2,"timestamp":1771967404167,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.070687,"impliedVol":0.8784,"impliedVolPercentile":0.8647},"requestUrl":"/m/hq/s/CAI/wiki","defaultTab":"wiki","newsList":[{"id":"1100915787","title":"Earning Preview: Caris Life Sciences, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are mixed","url":"https://stock-news.laohu8.com/highlight/detail?id=1100915787","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1100915787?lang=en_us&edition=fundamental","pubTime":"2026-02-19 17:41","pubTimestamp":1771494072,"startTime":"0","endTime":"0","summary":"Abstract Caris Life Sciences, Inc. will release its quarterly results on October 26, 2026 Post Market; this preview consolidates company data and market commentary to frame expectations for revenue,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Caris Life Sciences, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are mixed","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"gpt_icon":0},{"id":"2614672315","title":"Caris Life Sciences Inc  expected to post earnings of 3 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2614672315","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614672315?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:33","pubTimestamp":1771968786,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc  expected to post earnings of3cents a share - Earnings Preview Caris Life Sciences Inc CAI.OQ CAI.O is expected to  report resultson February 26 for the period ending December ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL8N3ZK2TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2613471471","title":"BRIEF-Caris Life Sciences Adds Breast Cancer Signature For Capecitabine To Ai Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=2613471471","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613471471?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:31","pubTimestamp":1771939908,"startTime":"0","endTime":"0","summary":"BRIEF-Caris Life Sciences Adds Breast Cancer Signature For Capecitabine To Ai InsightsFeb 24 (Reuters) - Caris Life Sciences Inc CAI.O:CARIS LIFE SCIENCES INC - ADDS BREAST CANCER SIGNATURE FOR CAPECI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK0PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4104","BK4139"],"gpt_icon":0},{"id":"2613714751","title":"Caris launches AI signature predicting capecitabine response in HER2-negative breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714751","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714751?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:31","pubTimestamp":1771939866,"startTime":"0","endTime":"0","summary":"Caris Life Sciences announced a new AI-powered breast cancer signature added to the Caris AI Insights section of its research-use-only Caris Molecular Tumor Board Report. The signature uses more than 2,000 gene expression and copy number features from Whole Exome and Whole Transcriptome profiling to predict response to the oral chemotherapy capecitabine as first-line treatment in HER2-negative breast cancer patients. The announcement does not say that these results were already presented or will be presented in the future.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL4Q7v1l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4139","BK4104"],"gpt_icon":0},{"id":"2613250714","title":"Caris Life Sciences Inc - Adds Breast Cancer Signature for Capecitabine to AI Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=2613250714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613250714?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:30","pubTimestamp":1771939859,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK0PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2613782279","title":"Caris Life Sciences to Participate in TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613782279","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613782279?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:30","pubTimestamp":1771853448,"startTime":"0","endTime":"0","summary":"Caris Life Sciences to Participate in TD Cowen 46th Annual Health Care Conference               Caris Life Sciences (NASDAQ: CAI) will participate in the TD Cowen 46th Annual Health Care Conference, h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL254Vl3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4139","BK4104"],"gpt_icon":0},{"id":"2612455977","title":"Caris Life Sciences Initiated at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2612455977","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612455977?lang=en_us&edition=fundamental","pubTime":"2026-02-17 18:30","pubTimestamp":1771324200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 17, 2026 05:30 ET (10:30 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"gpt_icon":0},{"id":"2612455637","title":"Caris Life Sciences initiated with an Outperform at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2612455637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612455637?lang=en_us&edition=fundamental","pubTime":"2026-02-17 18:05","pubTimestamp":1771322713,"startTime":"0","endTime":"0","summary":"Baird initiated coverage of Caris Life Sciences (CAI) with an Outperform rating and $26 price target Caris is a commercial-stage precision oncology...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-initiated-with-an-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-initiated-with-an-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"gpt_icon":0},{"id":"2611105881","title":"CAI Corp Completes Connected Deals, Boosts Controlling Shareholder’s Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2611105881","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611105881?lang=en_us&edition=fundamental","pubTime":"2026-02-16 13:07","pubTimestamp":1771218462,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) just unveiled an announcement. CAI Corp has completed previously announced discloseable and connected tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-completes-connected-deals-boosts-controlling-shareholders-stake?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-completes-connected-deals-boosts-controlling-shareholders-stake?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2611548361","title":"CAI Corp Updates Market on HK$0.14 Net Asset Value per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2611548361","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611548361?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:16","pubTimestamp":1770984983,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) just unveiled an update. CAI Corp has reported an unaudited net asset value per share of approximately H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-updates-market-on-hk0-14-net-asset-value-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-updates-market-on-hk0-14-net-asset-value-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2610643531","title":"CAI Corp Wins Strong Shareholder Backing for Equity Deals and 2026 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2610643531","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610643531?lang=en_us&edition=fundamental","pubTime":"2026-02-10 17:31","pubTimestamp":1770715860,"startTime":"0","endTime":"0","summary":"The latest announcement is out from China New Economy Fund Ltd. ( ($HK:0080) ). CAI Corp shareholders approved all resolutions at an extraordinary ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-wins-strong-shareholder-backing-for-equity-deals-and-2026-share-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-wins-strong-shareholder-backing-for-equity-deals-and-2026-share-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4215","BK4139","BK4104","CAI","EQR"],"gpt_icon":0},{"id":"2610653035","title":"Caris Life Sciences Inc. to report fourth quarter and full year 2025 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653035?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643842,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will host a conference call and live webcast at 3:30 p.m. CT  to discuss the results. The webcast can be accessed at Live Webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL3wVMkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2608847309","title":"Press Release: AudioCodes Reports Fourth Quarter and Full Year 2025 Results and Declares Semi-Annual Dividend of 20 cents per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2608847309","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608847309?lang=en_us&edition=fundamental","pubTime":"2026-02-03 15:00","pubTimestamp":1770102000,"startTime":"0","endTime":"0","summary":"-- Quarterly revenues increased by 1.7% year-over-year to $62.6 million;Full. year 2025 revenue increased by 1.4% to $245.6 million.-- Quarterly services revenues increased by 1.0% year-over-year to $34.6. million;Full year 2025 services revenues increased by 0.4% to $130.7. -- Quarterly GAAP net income was $1.9 million, or $0.07 per diluted. -- Full year 2025 GAAP net income was $9.0 million, or $0.31 per. quarter and $29.4 million for the full year 2025.EBITDA for the fourth quarter of 2025 was $4.9 million compared to $5.2 million for the fourth quarter of 2024. EBITDA was $18.3 million in 2025 compared to $21.1 million in 2024.On a Non-GAAP basis, EBITDA for the fourth quarter of 2025 was $6.5 million compared to $8.5 million for the fourth quarter of 2024. EBITDA was $24.8 million in 2025 compared to $31.4 million in 2024.On a Non-GAAP basis, net income was $4.5 million, or $0.16 per diluted share, for the fourth quarter of 2025 compared to $11.6 million, or $0.37 per diluted shar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4543","ARR","BK4023","BK4139","BK4104","BK4110","BK4585","BK4588","BK4587","BK4020","BK4528","BK4551","AUDC"],"gpt_icon":1},{"id":"2608880620","title":"CAI Corp Sets Out Board Line-Up and Committee Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2608880620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608880620?lang=en_us&edition=fundamental","pubTime":"2026-02-02 08:39","pubTimestamp":1769992768,"startTime":"0","endTime":"0","summary":"An announcement from China New Economy Fund Ltd. ( ($HK:0080) ) is now available. CAI Corp has announced the current composition of its board of di...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-sets-out-board-line-up-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-sets-out-board-line-up-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2607013613","title":"CAI Corp Executive Director Chan Cheong Yee to Resign in February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2607013613","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607013613?lang=en_us&edition=fundamental","pubTime":"2026-01-30 17:16","pubTimestamp":1769764570,"startTime":"0","endTime":"0","summary":"An announcement from China New Economy Fund Ltd. ( ($HK:0080) ) is now available. CAI Corp has announced that executive director Chan Cheong Yee wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-executive-director-chan-cheong-yee-to-resign-in-february-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-executive-director-chan-cheong-yee-to-resign-in-february-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2606110167","title":"Caris Life Sciences Identifies Key Resistance Mechanisms to Trastuzumab Deruxtecan in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2606110167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606110167?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:31","pubTimestamp":1769607086,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. has published a new study in Nature's npj Breast Cancer journal detailing mechanisms of resistance to trastuzumab deruxtecan  in metastatic breast cancer. The study, which analyzed real-world data from 2,799 T-DXd-treated patients, identified ERBB2  and ABCC1 as key transcriptomic predictors of overall survival specific to T-DXd treatment. Higher ERBB2 expression was associated with improved outcomes, while higher ABCC1 expression correlated with poorer outcomes, independent of HER2 category. The research also found that increased ABCC1 expression and enrichment of mutations in ERBB2, NFE2L2, KEAP1, and TOP1 were present in post-treatment samples, suggesting routes to acquired resistance. The results of this study have already been published.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpose","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL8B5W6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2606711710","title":"Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan","url":"https://stock-news.laohu8.com/highlight/detail?id=2606711710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606711710?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:30","pubTimestamp":1769607000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA93BCSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2605122164","title":"CAI Corp. to Seek Shareholder Approval for Equity Transfers, New Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2605122164","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605122164?lang=en_us&edition=fundamental","pubTime":"2026-01-21 12:06","pubTimestamp":1768968366,"startTime":"0","endTime":"0","summary":"CAI Corp.  will hold an extraordinary general meeting on Feb. 10 to seek shareholder approval for two equity transfer agreements involving share issuances, as well as the adoption of a new share scheme, according to a Tuesday Hong Kong bourse filing.Shares of the firm were down more than 1% in Wednesday morning trade.Under the proposals, shareholders will be asked to approve two equity transfer agreements with Longling Capital.The first transaction involves consideration of about HK$52.3 million, to be settled through the issue of up to 145.2 million new shares at an issue price of not less than HK$0.36 per share.The second transaction involves consideration of about HK$19.3 million, to be settled through the issue of up to 53.6 million new shares, also at a minimum issue price of HK$0.36 per share.Separately, the company is seeking approval to adopt a 2026 share scheme, under which the scheme mandate limit will be set at 5% of the total issued shares, excluding treasury shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1511","BK4585","EQR","BK4104","BK4588","BK4215","BK4139","00080","CAI"],"gpt_icon":0},{"id":"2604188151","title":"CAI Corp Calls EGM to Approve Share-Funded Acquisitions From Longling Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2604188151","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604188151?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:10","pubTimestamp":1768911052,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has shared an update. CAI Corp has called an extraordinary general meeting for 10 February 2026 in Hong ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-calls-egm-to-approve-share-funded-acquisitions-from-longling-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-calls-egm-to-approve-share-funded-acquisitions-from-longling-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2603167745","title":"CAI Corp Reports Unaudited Net Asset Value Per Share of HK$0.14 as of End-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2603167745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603167745?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:39","pubTimestamp":1768466342,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has provided an update. CAI Corp has announced that its unaudited net asset value per share stood at app...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-per-share-of-hk0-14-as-of-end-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-per-share-of-hk0-14-as-of-end-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4139","CAI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carislifesciences.com","stockEarnings":[{"period":"1week","weight":-0.1445},{"period":"1month","weight":-0.2944},{"period":"3month","weight":-0.3104},{"period":"6month","weight":-0.5385},{"period":"1year","weight":-0.16},{"period":"ytd","weight":-0.3462}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":0.003709},{"month":2,"riseRate":0.714286,"avgChangeRate":0.097096},{"month":3,"riseRate":0.785714,"avgChangeRate":0.045627},{"month":4,"riseRate":0.642857,"avgChangeRate":0.069907},{"month":5,"riseRate":0.571429,"avgChangeRate":0.009049},{"month":6,"riseRate":0.4,"avgChangeRate":0.003897},{"month":7,"riseRate":0.533333,"avgChangeRate":0.001503},{"month":8,"riseRate":0.466667,"avgChangeRate":0.000804},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.003567},{"month":10,"riseRate":0.666667,"avgChangeRate":0.042552},{"month":11,"riseRate":0.533333,"avgChangeRate":0.007248},{"month":12,"riseRate":0.4,"avgChangeRate":-0.027079}],"exchange":"NASDAQ","name":"Caris Life Sciences, Inc.","nameEN":"Caris Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Caris Life Sciences, Inc.,CAI,Caris Life Sciences, Inc.股票,Caris Life Sciences, Inc.股票老虎,Caris Life Sciences, Inc.股票老虎国际,Caris Life Sciences, Inc.行情,Caris Life Sciences, Inc.股票行情,Caris Life Sciences, Inc.股价,Caris Life Sciences, Inc.股市,Caris Life Sciences, Inc.股票价格,Caris Life Sciences, Inc.股票交易,Caris Life Sciences, Inc.股票购买,Caris Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction